Expression of tissue inhibitors of metalloproteinases (TIMPs) in gastric cancer

Digestive Diseases and Sciences

Volumn 45, Issue 1, 2000, Pages 114-121

  Joo, Young Eun ^a   Seo, Kang Seok ^a   Kim, Hyun Soo ^a   Rew, Jong Sun ^a   Park, Chang Soo ^a   Kim, Sei Jong ^a  

^a Chonnam National University Medical School   (South Korea)

Author keywords

Gastric cancer; Immunohistochemistry; In situ hybridization; TIMPs

Indexed keywords

MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CANCER;

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PROTEASE INHIBITORS; RNA, MESSENGER; STOMACH NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 0034001460     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005421713137     Document Type: Article

References (41)

1. 1. Goldfarb RH: Proteolytic enzymes in tumor invasion and degradation of host extracellular matrices. In Mechanisms of Cancer Metastasis. KV Honn, WE Powers, BF Sloane (eds). Boston, Nijhoff, 1986, pp 341-375
2. 2. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafdie S: Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67-68, 1980
3. 3. Hart IM, Saini A: Biology of tumor metastasis. Lancet 339:1453-1457, 1992
4. 4. Blasi F: Urokinase and urokinase receptor: A paracrine/autocrine system regulating cell migration and invasiveness. Bioassays 15:105-111, 1993
5. 5. Duffy MJ: The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis 10:145-155, 1992
6. 6. Dvorak HF: Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315:1650-1659, 1986
7. 7. Dano K, Anreason PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L: Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-166, 1985
8. 8. Liotta LA: Tumor invasion and metastases - role of the extracellular matrix. Rhoads memorial award lecture. Cancer Res 46:1-7, 1986
9. 9. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-336, 1991
10. 10. Moscatelli D, Rifkin DB: Membrane and matrix localization of proteinases: A common theme in tumor cell invasion and angiogenesis. Biochem Biophys Acta 48:67-85, 1989
11. 11. Matrisan LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125, 1990
12. 12. Murphy G, Reynolds JJ, Hembry RM: Metalloproteinases and cancer invasion and metastasis. Int J Cancer 44:757-760, 1989
13. 13. Murphy GJP, Murphy G, Reynolds JJ: The origin of the matrix metalloproteinases and their familial relationships. FEBS Lett 289:4-7, 1991
14. 14. James DE, Paula G, Anthony K, John PN: Role of matrix metalloproteinases and their inhibitors in pancreatic cancer. Digestion 58:520-528, 1997
15. 15. Stetler-Stevenson WG, Liotta LA, Kleiner DE: Extracellular matrix G: Role of metalloproteinases in tumor invasion and metastasis. FASEB J 7:1434-1441, 1993
16. 16. DeClerk YA, Imren S: Protease inhibitors: Role and potential therapeutic use in human cancer. Eur J Cancer 30A:2170-2180, 1994
17. 1 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 53:878-883, 1993
18. 18. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill FR: Levels of matrix metalloproteinases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53:5365-5369, 1993
19. 19. D'Errico A, Garbisa S, Liotta LA, Castranovo V, Stetler-Stevenson WG, Grigioni WF: Augmentation of collagenase IV, laminin receptor and Ki 62 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 4:239-246, 1991
20. 20. Murphy GJP, Reynolds JJ, Werb Z: Biosynthesis of tissue inhibitor of the metalloproteinases by human fibroblasts in culture. J Biol Chem 260:3079-3083, 1985
21. 21. Welgus HG, Stricklin GP: Human skin fibroblast collagenase inhibitor: Comparative studies in human connective tissues, serum, and amniotic fluid. J Biol Chem 258:12259-122643, 1983
22. 22. DeClerk Y, Yean TD, Ratzkin BJ, Lu HS, Langly KE: Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 264:17445-17453, 1989
23. 23. Liotta LA, Steeg PA, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell 64:327-326, 1991
24. 24. Zeng ZS, Cohen AM, Zahng ZF, Stetler-Stevenson WG, Guillem JG: Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastasis. Clin Cancer Res 1:899-906, 1995
25. 25. Kossakowska AE, Huchcroft SA, Urbanski SJ, Edwards DR: Comparative analysis of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-hodgkin's lymphomas in humans. Br J Cancer 73:1401-1408, 1996
26. 26. Visscher DW, Hoyhtya M, Ottosen SK, Liang C-M, Sarkar FH, Crissman JD, Fridman R: Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int J Cancer 59:339-344, 1994
27. 27. Nomura H, Fugimoto N, Seiki M, Mai M, Okada Y: Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinse A) in human gastric carcinomas. Int J Cancer 69:9-16, 1996
28. 28. Mimori K, Mori M, Shiraishi T, Fujie T, Baba K, Haraguchi M, Abe R, Ueo H, Akiyoshi T: Clinical significance of tissue inhibitor of metalloproteinase expression in gastric carcinoma. Br J Cancer 76(4):531-536, 1997
29. 29. Hoyhta M, Fridman R, Komarek D, Porter-Jordan K, Stetler-Stevenson WG, Liotta LA, Liang CM: Immunohistochemical localization of matrix metalloproteinase 2 and its specific inhibitor TIMP-2 in neoplastic tissues with monoclonal antibodies. Int J Cancer 56:500-505, 1994
30. 30. Park CS, Manahan LJ, Brigati DJ: Automated molecular pathology: One-hour in situ hybridization. J Histotechnol 2:462-467, 1995
31. 31. Reed JA, Manahan LJ, Park CS, Brigati DJ: Complete one-hour immunohistochemistry based on capillary action. Biotechniques 13:434-443, 1992
32. 32. Ponton A, Coulombe B, Skup D: Decreased expression of tissue inhibitor of the metalloproteinases in metastatic tumor cells leading to increased levels of collagenase activity. Cancer Res 51:2138-2143, 1991
33. 33. Azuma M, Tamatani T, Fukui K, Yoshida H, Kamogashira T, Ogino K, Suzuki T, Sato M: Role of plasminogen activators, metalloproteinases and the tissue inhibitor of metalloproteinase-1 in the metastatic process of human salivary-gland adenocarcinoma cells. Int J Cancer 54:669-676, 1993
34. 34. Sato H, Kida Y, Mai M, Endo Y, Saakai T, Tanaka J, Seiki M: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various tumor cells. Oncogene 7:77-83, 1992
35. 35. Miyagi E, Yasumitsu H, Hirahara F, Minaguchi H, Koshikawa N, Miyazaki K, Umeda M: Characterization of matrix-degrading proteinases and their inhibitors secreted by gynecological carcinoma cells. Jpn J Cancer Res 86:568-576, 1995
36. 36. Mohanam S, Wang SW, Rayford A, Yamamoto M, Sawaya R, Nakajima M, Liotta LA, Nicolson GL, Stetler-Stevenson WG, Rao JS: Expression of tissue inhibitors of metalloproteinases: Negative regulators of human glioblastoma invasion in vivo. Clin Exp Metastasis 13:57-62, 1995
37. 37. Grigioni WF, D'Errico A, Fortunato C, Fiorentino M, Mancini AM, Stetler-Stevenson WG, Sobel ME, Liotta LA, Onisto M, Garbisa S: Prognosis of gastric carcinoma revealed by interactions between tumor cells and basement membrane. Mod Pathol 7:220-225, 1994
38. 38. Stetler-Stevenson WG, Brown PD, Onisto M, Levy AT, Liotta LA: Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues. J Biol Chem 265:13933-13938, 1990
39. 39. Jessup JM: Cathepsin B and other proteases in human colorectal carcinoma. Am J Pathol 145:253-262, 1994
40. 40. Lefebvre V, Peeters-Joris C, Vaes G: Modulation by interleukin 1 and tumor necrosis facter alpha of production of collagenase, tissue inhibitor of metalloproteinases and collagen types in differentiated and dedifferentiated articular chondrocytes. Biochim Biophys Acta 1052:366-378, 1990
41. 41. McCune BK, Mullin BR, Flanders KC, Jaffurs WJ, Mullen LT, Sporn MB: Localization of transforming growth factor-β isotypes in lesions of the human breast. Hum Pathol 23:13-20, 1992